- Investing Ideas
- /
- Healthcare Sector
Healthcare Sector
UPDATED Apr 24, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
94 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SAN | €88.85 | 3.1% | -13.3% | €110.9b | €107.76 | PE20.5x | E13.6% | 4.2% | Pharmaceuticals & Biotech | ||
EL | €204.70 | 1.7% | 12.1% | €92.5b | €205.89 | PE40.4x | E13.7% | 1.9% | Healthcare | ||
DIM | €208.30 | -16.2% | -13.2% | €20.3b | €251.33 | PE79.6x | E23.3% | 0.3% | Pharmaceuticals & Biotech | ||
BIM | €100.70 | 0.6% | 6.8% | €11.9b | €112.21 | PE33.3x | E14.2% | 0.8% | Healthcare | ||
ERF | €56.84 | -3.5% | -7.8% | €11.0b | €60.00 | PE42.7x | E20.0% | 0.9% | Pharmaceuticals & Biotech | ||
IPN | €112.30 | 5.5% | 5.1% | €9.3b | €124.76 | PE15x | E6.2% | 1.1% | Pharmaceuticals & Biotech | ||
VIRP | €359.00 | -2.6% | 17.9% | €3.0b | €361.56 | PE24.8x | E11.2% | 0.4% | Pharmaceuticals & Biotech | ||
ORP | €12.65 | 13.2% | -99.5% | €2.0b | €10,975.00 | PE-0.5x | E99.2% | 0% | Healthcare | ||
GDS | €12.50 | -2.7% | -35.9% | €1.4b | n/a | PB1.1x | n/a | 0% | Healthcare | ||
VETO | €98.90 | 1.1% | 16.8% | €1.2b | €108.42 | PE21x | E5.0% | 0.9% | Pharmaceuticals & Biotech | ||
ABVX | €15.18 | 7.2% | 2.8% | €955.1m | €35.74 | PS212.6x | E14.6% | n/a | Pharmaceuticals & Biotech | ||
EQS | €59.40 | 1.0% | -17.4% | €893.0m | €71.25 | PE18.4x | E6.0% | 1.9% | Healthcare | ||
BOI | €34.00 | 1.2% | -10.5% | €590.3m | €39.60 | PE12.4x | E-0.3% | 3.2% | Pharmaceuticals & Biotech | ||
VLA | €3.59 | -0.3% | -17.0% | €498.0m | €8.95 | PS3.2x | E50.9% | n/a | Pharmaceuticals & Biotech | ||
GBT | €35.50 | 8.6% | 114.6% | €446.5m | €38.63 | PE18.7x | E22.8% | 1.4% | Healthcare | ||
MEDCL | €12.10 | 6.5% | 36.6% | €347.9m | €16.75 | PS24.6x | E68.2% | n/a | Pharmaceuticals & Biotech | ||
NANO | €5.54 | 5.7% | 159.9% | €260.8m | €11.30 | PS38.7x | E9.5% | n/a | Pharmaceuticals & Biotech | ||
EAPI | €2.69 | 0.4% | -74.7% | €254.7m | €4.72 | PB0.3x | E85.2% | n/a | Pharmaceuticals & Biotech | ||
ALSEN | €0.72 | 2.8% | 128.5% | €198.9m | €2.38 | PS35.7x | E42.8% | n/a | Pharmaceuticals & Biotech | ||
LNA | €19.24 | -1.1% | -37.8% | €196.8m | €32.50 | PE8.4x | E14.0% | 3.1% | Healthcare | ||
CGM | €13.50 | -3.6% | -28.3% | €184.1m | €20.70 | PB0.7x | E97.3% | n/a | Healthcare | ||
IPH | €2.24 | 3.5% | -16.0% | €180.7m | €6.27 | PS2.9x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
CLARI | €1.66 | 3.0% | -77.8% | €177.7m | €3.83 | PB0.05x | E104.1% | 0% | Healthcare | ||
ALCLS | €2.41 | 2.6% | 35.9% | €172.6m | n/a | PS7.5x | E45.9% | n/a | Pharmaceuticals & Biotech |